Cash, Cash Equivalents, and Financial Instruments

6 Months Ended

Jun. 30, 2022

Cash and Cash Equivalents [Abstract]

Cash, Cash Equivalents, and Financial Instruments

The following table shows the Company’s cash, cash equivalents, and marketable securities by significant investment category as of June 30, 2022:


	As of June 30, 2022
	Adjusted Cost		Allowance for Credit Losses		Total Unrealized Gains		Total Unrealized Losses		Fair Value		Cash and Cash Equivalents		Marketable Securities
(in thousands)
Cash	$	128,989	$	—	$	—	$	—	$	128,989	$	128,989	$	—
Level 1:
Commercial paper	27,842		—		—		(20)		27,822		16,635		11,187
Subtotal	27,842		—		—		(20)		27,822		16,635		11,187
Level 2:
Corporate debt securities	47,408		—		—		(239)		47,169		2,147		45,022
U.S. treasury securities	27,422		—		—		(84)		27,338		—		27,338
Subtotal	74,830		—		—		(323)		74,507		2,147		72,360
Total	$	231,661	$	—	$	—	$	(343)	$	231,318	$	147,771	$	83,547

Marketable securities held as of June 30, 2022 generally mature over the next one to eighteen months.

As of December 31, 2021 the Company had cash and cash equivalents of $241.6 million including $106.0 million in money market funds with no unrealized gains or losses.